Revance Therapeutics, Inc. (RVNC)
NASDAQ: RVNC · Real-Time Price · USD
3.090
+0.020 (0.65%)
At close: Dec 20, 2024, 4:00 PM
3.050
-0.040 (-1.29%)
After-hours: Dec 20, 2024, 4:47 PM EST
Revance Therapeutics Market Cap
Revance Therapeutics has a market cap or net worth of $324.15 million as of December 20, 2024. Its market cap has decreased by -47.94% in one year.
Market Cap
324.15M
Enterprise Value
623.52M
1-Year Change
-47.94%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since February 6, 2014, Revance Therapeutics's market cap has decreased from $453.20M to $324.15M, a decrease of -28.48%. That is a compound annual growth rate of -3.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 324.10M | -58.01% |
| Dec 29, 2023 | 771.90M | -49.18% |
| Dec 30, 2022 | 1.52B | 29.62% |
| Dec 31, 2021 | 1.17B | -37.87% |
| Dec 31, 2020 | 1.89B | 157.62% |
| Dec 31, 2019 | 732.10M | -1.68% |
| Dec 31, 2018 | 744.60M | -32.67% |
| Dec 29, 2017 | 1.11B | 87.35% |
| Dec 30, 2016 | 590.30M | -38.42% |
| Dec 31, 2015 | 958.60M | 138.58% |
| Dec 31, 2014 | 401.80M | -11.34% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurogene | 327.34M |
| Corvus Pharmaceuticals | 327.07M |
| Candel Therapeutics | 323.46M |
| Acelyrin | 323.05M |
| Jasper Therapeutics | 322.98M |
| Trevi Therapeutics | 318.99M |
| AirSculpt Technologies | 317.77M |
| Eton Pharmaceuticals | 317.27M |